Android app Apple app link

ADC Therapeutics (ADCT) Secures PIPE Financing, Price Target Adjusted

By Yahoo! Finance   |   1 month ago
ADC Therapeutics (ADCT) Secures PIPE Financing, Price Target Adjusted

Billionaire Steve Cohen backs ADC Therapeutics S.A. (NYSE:ADCT) as a small-cap stock with high growth potential. Recent $60 million financing deal strengthens the company's balance sheet, enhancing its position in cancer therapy market with proprietary technology.

Read More

Did you find this insightful?

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.